Globe Life Inc. Q1 Financial Report: Strong Earnings and Growth Outlook
Globe Life Inc. reported notable financial performance in the first quarter, with net operating income reaching $274 million, or $3.43 per share, reflecting a 12% increase from the previous year. Co-Chairman and Co-CEO Frank M. Svoboda highlighted these results, noting an anticipated rise in full-year earnings per share ranging from $15.40 to $15.90. This outlook revision stems from expected share repurchases, updates to assumptions, and improved investment income.
The company has stepped up its share buyback activities, purchasing approximately 1.4 million shares for $205 million during the quarter and revising its full-year repurchase forecast to $560–$610 million. This increase is supported by an excess cash flow projection of $650–$700 million, alongside a proposed 22% increase in dividend rates. Globe Life has seen substantial health sales growth, with health net sales up by 58% and premium revenue climbing by 13% to $417 million, bolstered by Medicare Supplement rate adjustments.
Svoboda reported that the company's GAAP return on equity was 17.9% for the quarter, with book value per share standing at $77.03. Excluding accumulated other comprehensive income (AOCI), the return on equity was 14%, with a book value per share of $98.56, marking a 12% rise from the prior year. In terms of revenue, the insurance operations experienced a 6% year-over-year increase in total premium revenue for the quarter, with expectations for a 7% growth over the full year.
Life insurance premiums grew by 3% to $853 million, while health insurance premiums saw a 13% increase to $417 million. The company projects continued premium growth in both segments, supported by robust sales and strategic rate increases. Administrative expenses amounted to $94 million, up 8% from the previous year. The company anticipates these expenses to represent about 7.3% of premium for the year, with artificial intelligence tools potentially mitigating future expense growth.
Co-Chairman and Co-CEO J. Matthew Darden commented on growth expectations, noting enhancements in productivity and sales across different divisions. In its investment portfolio, Globe Life allocated $419 million to fixed maturities with an average yield of 6.23% and invested $147 million in commercial mortgage loans and similar long-term instruments. The company highlighted an average yield on long-term invested assets of 5.5% for the quarter.
Regarding capital management, CFO Thomas P. Kalmbach indicated that the firm plans to end the year with liquid assets between $50 million and $60 million, maintaining a consolidated RBC ratio target of 300% to 320%. Globe Life, trading under the ticker GL on the New York Stock Exchange, offers life and supplemental health insurance products through multiple subsidiaries including Globe Life, American Income Life, and Liberty National.
The company's portfolio covers term and whole life insurance, fixed annuities, and supplemental health policies suitable for diverse consumer needs. The comprehensive financial and strategic overview presents a positive outlook for Globe Life's operations and market performance.